IRIS
GENTILE, Ivan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 14.233
NA - Nord America 12.188
EU - Europa 8.893
SA - Sud America 1.585
Continente sconosciuto - Info sul continente non disponibili 599
AF - Africa 396
OC - Oceania 20
Totale 37.914
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.557
SG - Singapore 6.014
RU - Federazione Russa 4.255
CN - Cina 2.869
VN - Vietnam 2.568
IT - Italia 1.832
BR - Brasile 1.272
HK - Hong Kong 1.020
DE - Germania 547
NL - Olanda 509
FR - Francia 458
BD - Bangladesh 365
CA - Canada 347
JP - Giappone 293
FI - Finlandia 279
GB - Regno Unito 260
IN - India 234
KR - Corea 202
IE - Irlanda 183
MX - Messico 136
AR - Argentina 127
ZA - Sudafrica 111
UA - Ucraina 107
IQ - Iraq 106
CI - Costa d'Avorio 94
PL - Polonia 89
SE - Svezia 71
PH - Filippine 70
TH - Thailandia 65
ES - Italia 60
AT - Austria 58
ID - Indonesia 57
EC - Ecuador 50
TR - Turchia 48
PK - Pakistan 43
TW - Taiwan 42
CO - Colombia 36
LT - Lituania 35
MA - Marocco 33
UZ - Uzbekistan 32
EG - Egitto 30
VE - Venezuela 30
JM - Giamaica 28
KE - Kenya 25
SA - Arabia Saudita 23
CL - Cile 22
AE - Emirati Arabi Uniti 20
JO - Giordania 20
DZ - Algeria 19
CR - Costa Rica 18
CH - Svizzera 17
PY - Paraguay 17
TN - Tunisia 17
MY - Malesia 16
NP - Nepal 16
CZ - Repubblica Ceca 15
BE - Belgio 14
SV - El Salvador 14
NI - Nicaragua 13
KZ - Kazakistan 12
AL - Albania 11
AU - Australia 11
ET - Etiopia 11
IR - Iran 11
RS - Serbia 11
DO - Repubblica Dominicana 10
GT - Guatemala 10
HN - Honduras 10
LV - Lettonia 10
OM - Oman 10
IL - Israele 9
PE - Perù 9
RO - Romania 9
UY - Uruguay 9
AZ - Azerbaigian 8
BG - Bulgaria 8
BO - Bolivia 8
LB - Libano 8
BB - Barbados 7
NG - Nigeria 7
SN - Senegal 7
AO - Angola 6
NZ - Nuova Zelanda 6
PR - Porto Rico 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
GR - Grecia 5
HR - Croazia 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
AF - Afghanistan, Repubblica islamica di 4
BS - Bahamas 4
BW - Botswana 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
GE - Georgia 4
HU - Ungheria 4
KW - Kuwait 4
Totale 37.205
Salva come PNG Salva come JPEG
Città #
Singapore 2.964
San Jose 2.329
Ashburn 1.147
Moscow 1.045
Hong Kong 970
Hefei 913
Ho Chi Minh City 710
Beijing 690
Chandler 620
Hanoi 598
Naples 578
Santa Clara 528
Los Angeles 417
Amsterdam 407
The Dalles 353
Council Bluffs 335
Lauterbourg 293
Tokyo 272
New York 259
Millbury 246
Munich 204
Seoul 168
Dallas 152
Des Moines 151
São Paulo 148
Boston 146
Redondo Beach 138
Princeton 137
Buffalo 133
Nanjing 129
Napoli 129
Da Nang 116
Haiphong 105
Frankfurt am Main 101
Ottawa 101
Phoenix 99
Orem 94
Seattle 91
Lawrence 90
Rome 88
Montreal 84
Chicago 80
Milan 79
Warsaw 79
Brooklyn 74
Nuremberg 72
Turku 72
Houston 70
Boardman 68
Wilmington 66
Mexico City 58
Helsinki 56
Toronto 55
Denver 54
Chennai 51
Johannesburg 50
London 49
Atlanta 48
Baghdad 48
Poplar 46
Stockholm 46
Jacksonville 42
Nanchang 42
Rio de Janeiro 40
San Francisco 40
Hải Dương 38
Biên Hòa 36
Dublin 36
Bangkok 31
Can Tho 30
Manchester 29
Shenyang 29
Tashkent 29
Washington 29
Charlotte 28
Falkenstein 28
Lappeenranta 28
Hebei 26
Belo Horizonte 24
Curitiba 24
Ninh Bình 24
Querétaro 24
Thái Nguyên 24
Tianjin 24
Bologna 22
Düsseldorf 22
Jiaxing 22
Ankara 21
Dhaka 21
Porto Alegre 21
Brasília 20
Nairobi 20
Bắc Giang 19
Changsha 19
New Delhi 19
Vienna 19
Bến Tre 18
Guangzhou 18
Guarulhos 18
Kingston 18
Totale 20.521
Salva come PNG Salva come JPEG
Nome #
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 211
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 202
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection 196
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 189
[HBV and pregnancy]. 189
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Series 186
A transient increase in the serum ancas in patients with sars-cov-2 infection: A signal of subclinical vasculitis or an epiphenomenon with no clinical manifestations? a pilot study 185
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 184
Febbre di origine sconosciuta (FUO): nostra casistica 183
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 179
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 179
Hepatitis C screening in the Emergency Department of a large hospital in southern Italy: results of a pilot study 176
Successful treatment of post-surgical osteomyelitis caused by XDR Pseudomonas aeruginosa with ceftolozane/tazobactam monotherapy 172
Loss of Detection of sgN Precedes Viral Abridged Replication in COVID-19-Affected Patients—A Target for SARS-CoV-2 Propagation 172
Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. 170
A CASE OF PEGYLATED INTERFERON ALPHA-RELATED DIABETIC KETOACIDOSIS: CAN THIS COMPLICATION BE AVOIDED? 169
Invasive Fungal Infections in Hospitalized Patients with COVID-19: A Non-Intensive Care Single-Centre Experience during the First Pandemic Waves 168
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C 164
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 163
A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19 162
Nirmatrelvir/Ritonavir and Molnupiravir in the Treatment of Mild/Moderate COVID-19: Results of a Real-Life Study 162
Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 160
Germline rare variants of lectin pathway genes predispose to asymptomatic SARS-CoV-2 infection in elderly individuals 160
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 159
Prevalence and risk factors of erectile dysfunction in patients with hepatitis B virus or hepatitis C virus or chronic liver disease: Results from a prospective study 159
Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019 (COVID-19) 159
Diabetes and COVID-19: The potential role of mTOR 157
Clinical Features of Patients with Home Isolation Sars-Cov-2 Infection: A Multicenter Retrospective Study in Southern Italy 157
Pneumocystis jirovecii pneumonia in an immunocompetent patient recovered from COVID-19 157
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 156
Hemolytic anemia during pegylated interferon alpha 2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. A case report 155
A SIMPLE NONINVASIVE SCORE PREDICTS GASTROESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS. 155
Asunaprevir for hepatitis C: A safety evaluation 155
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 154
Low vitamin D levels are associated with the presence of serum cryoglobulins in patients with chronic HCV infection 154
Rara e grave manifestazione dell’infezione da HHV-6: la sindrome DRESS. 153
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 153
Trabecular bone score assessed by dual-energy X ray absorption predicts vertebral fractures in HIV infected young adults 152
MK-5172 : a second-generation protease inhibitor for the treatment of hepatitis C virus infection. 152
COVID-19 chest CT and laboratory features of B.1.617.2 (Delta variant) vs B.1.1.7 (Alpha variant) surge: a single center case-control study 151
HIV and hepatitis C virus: facts and controversies 151
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection 151
The MBL2 genotype relates to COVID-19 severity and may help to select the optimal therapy 150
Does compulsory vaccination limit personal freedom? Ethical issues 150
Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort) 150
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 149
Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study (Journal of Neurology, (2022), 269, 6, (3301-3307), 10.1007/s00415-022-11009-x) 149
Investigational direct-acting antivirals in hepatitis C treatment: The latest drugs in clinical development 149
Bulevirtide Treatment of Hepatitis Delta Virus Infection in a Kidney Transplant Recipient: A Case Report 148
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study 148
Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art 148
Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis 148
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014 148
Further findings concerning endothelial damage in covid-19 patients 148
B-Type Natriuretic Peptides and High-Sensitive Troponin I as COVID-19 Survival Factors: Which One Is the Best Performer? 146
Cytometric analysis of patients with COVID-19: what is changed in the second wave? 146
Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients 146
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 145
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 145
Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis 145
The tnfrsf13c h159y variant is associated with severe covid-19: A retrospective study of 500 patients from southern italy 145
Molecular fingerprint by omics‐based approaches in saliva from patients affected by SARS‐CoV‐2 infection 144
Vitamin D deficiency is an independent risk factor and is predictor of infections in patients affected by HCV-related liver cirrhosis 144
mTOR Inhibitor Use Is Associated With a Favorable Outcome of COVID-19 in Patients of Kidney Transplant: Results of a Retrospective Study 143
Impact of oral antiviral therapy against HCV on gut microbiota. A prospective study 143
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort) 143
Inducible Nitric Oxide Synthase (iNOS): Why a Different Production in COVID-19 Patients of the Two Waves? 143
Diabetes and SARS-CoV-2 Infection: The Potential Role of Antidiabetic Therapy in the Evolution of COVID-19 142
COVID-19 in patients with thymic epithelial tumors with or without Good's syndrome: a single-center retrospective study 142
Anti-HBc positivity was associated with histological cirrhosis in patients with chronic hepatitis C. 142
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir 142
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 141
Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients 141
A survey on antibiotic therapy knowledge among physicians of a tertiary care and university hospital 141
Risk of invasive fungal infections among patients treated with disease modifying treatments for multiple sclerosis: a comprehensive review 141
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 140
Serum Galectin-3 and Aldosterone: potential biomarkers of cardiac complications in patients with COVID-19 140
Trends in Caesarean Section Rate According to Robson Group Classification among Pregnant Women with SARS-CoV-2 Infection: A Single-Center Large Cohort Study in Italy 139
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 139
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 139
Novel strategies for the management of bacterial and fungal infections in patients with liver cirrhosis: focus on new antimicrobials 139
Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience 138
Beclabuvir for the treatment of hepatitis C 138
Bacteremic nosocomial pneumonia caused by Gram-negative bacilli: results from the nationwide ALARICO study in Italy 136
Virological patterns of HCV patients with failure to interferon-free regimens 136
Prevalence of HSV1/2 congenital infection assessed through genome detection on dried blood spot in individuals with autism spectrum disorders 136
Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn's disease 136
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 136
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 136
Serum KL-6 could represent a reliable indicator of unfavourable outcome in patients with COVID-19 pneumonia 136
COVID-19 in solid organ transplant recipients after 2 years of pandemic: Outcome and impact of antiviral treatments in a single-center study 136
Microbiota and hepatitis C virus in the era of direct-acting antiviral agents 135
Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study 135
COVID-19 Post-Exposure Evaluation (COPE) Study: Assessing the Role of Socio-Economic Factors in Household SARS-CoV-2 Transmission within Campania Region (Southern Italy) 135
Antibiotic prophylaxis and risk of infections in thyroid surgery: Results from a national study (UEC - Italian Endocrine Surgery Units Association) 135
Regulatory noncoding and predicted pathogenic coding variants of ccr5 predispose to severe covid-19 135
Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience 134
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 134
Prevalenza di infezioni da CMV, HHV-6 o EBV in bambini con disturbi dello spettro autistico. 134
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 134
Totale 15.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.227 0 0 20 11 8 39 24 46 163 78 286 552
2022/20231.962 233 113 53 99 214 209 34 172 316 377 83 59
2023/20241.601 78 222 295 99 94 182 40 153 32 24 233 149
2024/20259.684 367 371 54 170 241 599 980 593 749 1.038 3.573 949
2025/202620.262 2.119 1.669 2.196 2.066 3.263 906 2.290 1.149 2.128 1.229 600 647
2026/20271.435 344 786 305 0 0 0 0 0 0 0 0 0
Totale 37.914